Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Cogent Biosciences, Inc. Income Statement Banner

Cogent Biosciences, Inc. Income Statement

COGT Stock Analysis

Page title

Section title

Breakdown
2015
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
2.986M6.355M8.360M9.734M22.499M7.871M0.0000.0000.000
Cost of Revenue
0.0000.0000.0000.00043.709K25.738K147.000K5.878M3.588M
Gross Profit
2.986M6.355M8.360M9.734M22.455M7.845M-147.000k-5.878m-3.588m
Operating Expense
9.578M25.425M34.512M45.739M54.677M90.070M75.551M147.839M204.542M
Operating Income
-6.592m-19.070m-26.152m-36.005m-32.178m-82.199m-75.551m-147.839m-208.130m
Other Income Expense
0.000681.000K274.000K320.000K78.000K-246.000k2.811M3.609M0.000
Total Other Income Expense
0.000681.000K274.000K320.000K345.000K7.391M3.278M7.598M15.720M
Pretax Income
-6.592m-18.124m-25.492m-34.532m-31.833m-74.808m-72.273m-140.241m-192.410m
Tax Provision
0.000-265.000k-386.000k1.473M-1.560m-8.357m-467.000k-7.598m0.000
Net Income
-6.592m-18.124m-25.492m-34.532m-30.273m-66.451m-71.806m-132.643m-192.410m
Basic EPS
-1.130-3.100-3.450-5.550-3.970-6.000-1.850-2.260-2.420
Diluted EPS
-0.890-2.450-3.450-5.550-3.970-6.000-1.850-2.260-2.420
Basic Average Shares
5.855M5.855M7.396M6.224M7.620M11.081M38.731M58.740M79.658M
Diluted Average Shares
7.396M7.396M7.396M6.224M7.620M11.081M38.731M58.740M79.658M
Total Expenses
9.578M25.425M34.512M45.739M54.677M90.070M75.551M147.839M208.130M
Interest Income
0.000265.000K386.000K1.153M267.000K144.000K467.000K3.989M13.077M
Interest Expense
0.0000.0000.0000.0000.0000.0000.0003.989M0.000
EBITDA
-6.413m-18.240m-24.981m-34.684m-32.178m-89.692m-75.404m-147.839m-204.542m
Depreciation & Amortization
179.000K830.000K1.171M1.321M1.293M720.000K147.000K5.878M3.588M